HERTFORDSHIRE, England and
PITTSBURGH, Jan. 21, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ,
TASE: MYL) today announced that it will host a conference call and
live webcast, including a slide presentation, on Wednesday, Feb. 10, 2016, at 4:30 p.m. ET, to review the company's financial
results for the fourth quarter and year ended Dec. 31, 2015. The company also will provide its
financial guidance for 2016. Mylan will release its financial
results on Feb. 10, following the
close of the U.S. financial markets.
The dial-in number to access the earnings call
is 800.514.4861 or 678.809.2405 for
international callers. To access the live webcast, please log on to
Mylan's website, mylan.com, at least 15 minutes before the event is
scheduled to begin to register and download or install any
necessary software. A replay of the webcast will be available at
mylan.com/investors, for a limited time.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of more than 1,400 generic and branded pharmaceuticals,
including antiretroviral therapies on which nearly 50% of people
being treated for HIV/AIDS in the developing world depend. We
market our products in approximately 165 countries and territories.
Our global R&D and manufacturing platform includes more than 50
facilities, and we are one of the world's largest producers of
active pharmaceutical ingredients. Every member of our more than
30,000-strong workforce is dedicated to creating better health for
a better world, one person at a time. Learn more at mylan.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-to-report-fourth-quarter-and-full-year-2015-financial-results-on-feb-10-2016-300208040.html
SOURCE Mylan N.V.